Ketofen is recommended for the alleviation of inflammation and pain associated with musculoskeletal disorders in horses. The product is an FDA-approved non-narcotic, non-steroidal, anti-inflammatory agent with analgesic and antipyretic (prevent or reduce fever) properties. It significantly reduces hoof pain associated with chronic laminitis for up to six hours. Ketofen requires a prescription from your veterinarian.
- Recommended for the alleviation of inflammation and pain associated with musculoskeletal disorders in horses
- FDA-approved non-narcotic, non-steroidal anti-inflammatory agent with analgesic and antipyretic properties
- Significantly reduces hoof pain associated with chronic laminitis for up to six hours
- Showed significant intra-articular anti-inflammatory activity in an experimentally induced acute carpal synovitis model
How it works
Ketofen contains the active ingredient, Ketoprofen, which is a non-steroidal anti-inflammatory agent that helps alleviate pain and inflammation in horses.
Ketofen (ketoprofen) is recommended for the alleviation of inflammation and pain associated with musculoskeletal disorders in the horse.
is a non-steroidal anti-inflammatory drug (NSAID) and cyclo-oxygenase inhibitor used to treat mild to moderate pain, osteoarthritis, rheumatoid arthritis, and pain associated with musculoskeletal disorders in the horses.
It may also be used to treat other conditions as determined by your doctor.It is a potent analgesic, antipyretic and anti-inflammatory. Ketoprofen is most-commonly prescribed for musculoskeletal pain from soft-tissue injury, osteoarthritis or other bone and joint problems. It may be used to reduce or control fevers due to viral or bacterial infections.
View Ketofen Drug Facts Sheet.
The recommended dosage is 1 mg/lb (1 mL/100 lbs) of body weight once daily. Treatment is administered by intravenous injection and may be repeated for up to five days. Onset of activity is within two hours with peak response by 12 hours.
This product should not be used in breeding animals since the effects of Ketofen on fetility, pregnancy or fetal health in horses have not been determined.
There are no known contraindications to this drug when used as directed. Intra-arterial injection should be avoided. Do not use in a horse if it has previously shown hypersensitivity to ketoprofen.
Studies to determine activity of Ketofen when administered concomitantly with other drugs have not been conducted. Drug compatibility should be monitored closely in patients requiring adjunctive therapy.
Do not use in horses intended for human consumption.
During investigational studies, no significant side effects were reported.